Skip to main content
Clinical Trials/NCT03841903
NCT03841903
Completed
Not Applicable

Structural Analysis of Spinal Cord Grey and White Matter Changes in Patients With Multiple Sclerosis: Sub-study Within the Swiss Multiple Sclerosis Cohort (SMSC-study)

University Hospital, Basel, Switzerland1 site in 1 country79 target enrollmentJuly 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
University Hospital, Basel, Switzerland
Enrollment
79
Locations
1
Primary Endpoint
Change in SC atrophy assessed by MRI
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Research project in which patients with Multiple Sclerosis (MS) are examined clinically and with magnetic resonance imaging (MRI). To evaluate spinal cord (SC) grey and white matter changes (incl. lesions) using fast, high-resolution MRI sequences with high contrast between SC and cerebrospinal fluid (CSF) as well as high contrast within the SC (grey-white matter contrast).

Detailed Description

The Swiss Multiple Sclerosis Cohort (SMSC-Study) aims to better evaluate specific Multiple Sclerosis (MS) phenotypes through the systematic and standardised documentation and acquisition of clinical course and paraclinical tests such as magnetic resonance imaging (MRI), blood and cerebrospinal fluid (CSF) specimens. Determination of the relative contribution of SC metrics (cervical cord volume, cervical grey matter (GM) cord volume, cervical white matter (WM) cord volume, SC lesion load) to disability in MS.

Registry
clinicaltrials.gov
Start Date
July 1, 2017
End Date
March 24, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in SC atrophy assessed by MRI

Time Frame: at baseline and after 1 year

Determination of the degree of SC grey and white matter atrophy in MS patients with relapsing versus progressive disease courses in comparison to matched HC. Measurement tool is a structural MRI of the brain and spinal cord at 3 Tesla. Assessment will last approx. 90 minutes.

Secondary Outcomes

  • Change in Timed 25-foot walk test (T25-FW)(at baseline and after 1 year and after 5 years)
  • Change in Multiple Sclerosis Walking Scale-12 (MSWS-12) Questionnaire(at baseline and after 1 year and after 5 years)

Study Sites (1)

Loading locations...

Similar Trials